Libra Infusions Limited (DSE:LIBRAINFU)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
673.10
+1.40 (0.21%)
At close: Feb 26, 2026
-15.29%
Market Cap 1.52B
Revenue (ttm) 197.03M
Net Income (ttm) 1.58M
Shares Out 2.25M
EPS (ttm) 0.70
PE Ratio 957.24
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,629
Average Volume 9,814
Open 675.00
Previous Close 671.70
Day's Range 670.00 - 679.90
52-Week Range 594.20 - 850.00
Beta -0.49
RSI 55.82
Earnings Date n/a

About Libra Infusions

Libra Infusions Limited manufactures and sells intravenous fluids in Bangladesh. Its products are used in medical situations, including diarrhoeal disease, surgical operation, loss of blood, weakness, and hospitalization. The company offers LIBOTT, LIBOTT-10, LIBOTT-25, LIBOTT-S, LIBOTT-S JR, NORMASOL, BABY SALINE, DIASOL, HARTSOL, LIBRAZOL, LIBRACIN, LIBOTT-M, LIBRACIN-400, and LIBRET products. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999. Libra Infusions Limited was inc... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 699
Stock Exchange Dhaka Stock Exchange
Ticker Symbol LIBRAINFU
Full Company Profile

Financial Performance

In fiscal year 2019, Libra Infusions's revenue was 197.03 million, an increase of 3.31% compared to the previous year's 190.72 million. Earnings were 1.58 million, a decrease of -72.49%.

Financial Statements

News

There is no news available yet.